Arterial occlusion in patients with peripheral vascular disease treated with platinum-based regimens for lung cancer

Cancer Chemother Pharmacol. 1997;40(1):19-22. doi: 10.1007/s002800050619.

Abstract

Background: Patients with cancer may be hypercoagulable, and smoking can cause both lung cancer and peripheral vascular disease. Cisplatin-based chemotherapy has been reported to cause a variety of vascular side effects.

Case reports: Five patients with bronchogenic carcinoma and peripheral vascular disease developed acute arterial occlusion soon after receiving a combination of cisplatin or carboplatin plus etoposide. All these patients had risk factors for atherosclerosis and three of them had preexisting known peripheral vascular disease.

Conclusions: The occurrence of acute arterial occlusion soon after initiation of chemotherapy suggests that it might have been a complication of this therapy. Hence, caution should be exercised when using platinum-based (and other?) chemotherapy in patients with known moderate or severe peripheral vascular disease.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Arterial Occlusive Diseases / chemically induced*
  • Carboplatin / adverse effects*
  • Cisplatin / adverse effects*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Peripheral Vascular Diseases / complications*

Substances

  • Antineoplastic Agents
  • Carboplatin
  • Cisplatin